Ningbo Ouman Biotechnology Co., Ltd. is a high-tech pharmaceutical company, mother and father.
The Division is mainly engaged in the research and development of pharmaceutical intermediates and biopharmaceuticals.
The research and development of the year has been stable, fully recognized by the market and exported to Europe and the United States. Factory student
The workshop is designed and constructed in accordance with GMP standard. The company actively promotes the listing work.
The company now owns more than 20,000 square meters of land and more than 8,000 square meters of plant area. It has invested in research and development.
It costs over 20 million yuan and has first-class production line and technical personnel.
Designed and constructed according to GMP requirements, GMP certification is being actively obtained. The company has
After applying for invention patents and trademarks, he has more than 20 undergraduates and engineers.
More than 80 employees. The company has reached a number of multinational pharmaceutical companies.
Growth cooperation, and intend to invest in our biomedical companies, and several domestic companies
A large listed pharmaceutical company is also cooperating in depth. The company actively introduces investment and adjusts it.
The Pharmaceutical and Health Industry Association is the company's constant insistence on increasing production scale and production line.
In the future, the annual output value is expected to exceed 1 billion yuan and be listed successfully.
|Membership:||On ECPlaza since 2019|
|Main Item / Product:||IPTG,API,PHARMACEUTICAL,INTERMEDIATES,LAB CHEMICAL|
|Keywords:||Iptg, Pharmaceutical, Api|
|Main Target Region:||World Wide|
|Safety / Quality Approvals:||GMP|
|Representative / CEO's Name:||Mr.chen|
|Employees Total:||250 to 499|
|Annual Revenue:||More than US$1,000,000|
|Annual Export Rate:||50%|